Michael J. Doane, Ph.D.
Executive Director, Head of HEOR
Greater Boston · 1 connectionNot on Unlinked · Imported profile. Is this you? Claim it
Is this about you? Request removal
About
I am a Director of Health Economics and Outcomes Research (HEOR) at Alkermes, Inc. I conduct HEOR-related activities supporting ALKS 3831, which is an investigational, novel oral atypical antipsychotic drug candidate for the treatment of schizophrenia. My expertise is in the use and analysis of patient-reported outcome measures to quantify disease burden and identify unmet patient needs. I was previously a Manager of Health Outcomes Research at Kantar Health with experience evaluating the humanistic and economic impact of medical conditions and their treatments. In my client-facing role, I collaborated with pharmaceutical and biotechnology companies to develop research strategies that support pharmaceutical products across their lifecycles. I gained experience generating real-world evidence through rigorous quantitative methods across various therapeutic areas (e.g., oncology, psychiatry/psychology, cardiovascular diseases, rare diseases, and diabetes). Projects included: custom observational studies among patients, caregivers, and physicians, patient preference studies, physician chart reviews, and analyses of medical claims.
Experience
May 2012 to Aug 2016
Jan 2015 to May 2015
Aug 2013 to May 2014
Education
Doctor of Philosophy (Ph.D.) Social Psychology
2011 to 2017
Master of Arts (M.A.) Social Psychology
2011 to 2013
Bachelor of Arts (B.A.) Psychology
2007 to 2011
Study Abroad Psychology
2009 to 2009